FBR president: Impeding animal research will harm animals | Animal studies result in innovative treatments for dogs, cats | Experimental injection reversed type 1 diabetes in mouse study
August 22, 2018
FBR Smartbrief
SIGN UP ⋅   FORWARD
Top Stories
FBR president: Impeding animal research will harm animals
Colorado State University's Flint Animal Cancer Center is leading a clinical trial of a vaccine that might prevent all canine cancers, and about 800 people have enrolled their dogs in the placebo-controlled study, writes Foundation for Biomedical Research President Matthew R. Bailey. Research in animals has yielded vaccines for feline leukemia virus and treatments for canine arthritis, and research is underway on treatments for feline kidney disease, feline infectious peritonitis, canine epilepsy, feline oral squamous cell carcinoma, canine brain tumors and other diseases that affect pets and the people who love them. "Impeding this research, as some so-called animal rights activists would have us do, would be a disaster for pets and people alike," Bailey writes.
Houston Chronicle (tiered subscription model) (8/21) 
LinkedIn Twitter Facebook Google+ Email
Animal studies result in innovative treatments for dogs, cats
Animal studies result in innovative treatments for dogs, cats
(Jack Guez/AFP/Getty Images)
An innovative new drug recently restored the vision of a dog with lymphoma whose owner enrolled him in a clinical trial, an experimental treatment extended the lifespan of almost 70% of dogs with osteosarcoma in another clinical trial and a different treatment cleared left ventricle blockage in cats, and treatments for animals could also be used to save human lives, says Foundation for Biomedical Research President Matthew R. Bailey. These are only a few examples of treatments tested on animals that will save animals' lives and highlight why opposition to animal studies is misguided, Bailey notes.
Leavenworth Times (Kan.) (8/15) 
LinkedIn Twitter Facebook Google+ Email
 
Research Breakthroughs
Experimental injection reversed type 1 diabetes in mouse study
Researchers at Purdue University and the Indiana University School of Medicine are developing a therapy that reversed type 1 diabetes within 24 hours and allowed mice to maintain insulin independence for at least 90 days. The treatment consists of islet cells in a collagen solution for subcutaneous injection, and the formulation will be tested in diabetic dogs, possibly using pig islet or stem cells.
Clinical Innovation + Technology online (8/21) 
LinkedIn Twitter Facebook Google+ Email
Study in dogs shows experimental gene therapy restores night vision
Study in dogs shows experimental gene therapy restores night vision
(Pixabay)
An experimental gene therapy reversed loss of night vision in six dogs with an inherited retinal disorder, and the treatment may offer hope for people with rhodopsin gene mutations, which cause about 20% of retinitis pigmentosa cases. The therapy, described in Proceedings of the National Academy of Sciences, disables both the normal and mutated copies of the gene and substitutes a healthy copy of the gene to make the light-sensing protein.
The Philadelphia Inquirer/Daily News (tiered subscription model) (8/20),  United Press International (8/21) 
LinkedIn Twitter Facebook Google+ Email
 
Airway stem cell transplants for cystic fibrosis studied in mice
Transplants of healthy, corrected stem cells transplanted into the nasal airways of mouse models of cystic fibrosis resulted in continued reproduction of healthy cells, researchers at the University of Adelaide in Australia reported in the journal Stem Cell Research & Therapy. The study team is seeking to develop a gene therapy for cystic fibrosis similar to bone marrow transplants used to treat immunodeficiency disorders.
Rare Disease Report (8/17) 
LinkedIn Twitter Facebook Google+ Email
Other News
Animal Health
2nd contagious cancer bedevils endangered Australian marsupial
Australia's Tasmanian devil population has been devastated by a facial tumor disease, and scientists have identified a similar but distinct contagious cancer that may pose a greater threat. Research on the emerging cancer may aid the development of an effective vaccine, could reveal how cancers avoid the immune system and, because contagious cancer cells are similar to organ transplants, might lead to new methods of preventing transplant rejection, researchers write in eLife.
United Press International (8/16) 
LinkedIn Twitter Facebook Google+ Email
Policy News
Medical school's partnership with zoo gives students a unique perspective
Harvard Medical School's partnership with Franklin Park Zoo teaches medical students about One Health concepts, has spawned research projects and offers real-life experience performing procedures. The first student in the program describes his experience in a JAMA article.
Medscape (free registration) (8/17) 
LinkedIn Twitter Facebook Google+ Email
Other News
Animal Rights Activity
Shutting down animal research projects is a failure, not a victory
Animals are the primary beneficiaries of animal research, which has yielded vaccines, surgical procedures and drugs that prevent disease and help sick animals, Foundation for Biomedical Research President Matthew R. Bailey writes. "The success several animal rights activists have had shutting down animal research projects this year hardly represents a victory for animal rights," Bailey writes.
Science (free content) (8/17) 
LinkedIn Twitter Facebook Google+ Email
FBR News
Donate to FBR
For 35 years, FBR has advanced biomedical research for the sake of both human and animal health. We can't do our job without your support. Please give what you can. Together we will continue to make a difference.
LinkedIn Twitter Facebook Google+ Email
 
  
  
In the affairs of this world, poverty alone is without envy.
Giovanni Boccaccio,
writer
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about FBR:
About FBR | Donate
About FBR
The Foundation for Biomedical Research (FBR) is the nation’s oldest and largest non-profit dedicated to improving human and animal health by promoting public understanding and support for biomedical research. Our mission is to educate people about the essential role animal research plays in the quest for medical advancements, treatments and cures for both people and animals.
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Melissa Turner
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2018 SmartBrief, Inc.®
Privacy Policy (updated May 25, 2018) |  Legal Information